Effects of emulsified isoflurane on haemodynamics and cardiomyocyte apoptosis in rats with myocardial ischaemia

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 8, 2009, Pages 776-783

  Hu, Zhao Yang ^a   Liu, Jin ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

Apoptosis; Emulsified isoflurane; Myocardial ischaemia; Myocardial preconditioning

Indexed keywords

CASPASE 3; EMULSIFIED ISOFLURANE; INTRALIPID; ISOFLURANE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL RAT; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MEASUREMENT; NONHUMAN; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOOD PRESSURE; CARDIOTONIC AGENTS; CASPASE 3; DISEASE MODELS, ANIMAL; DRUG COMPOUNDING; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FEMALE; HEART RATE; HEMODYNAMICS; INFUSIONS, INTRAVENOUS; ISOFLURANE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; STROKE VOLUME;

EID: 68549118926     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05138.x     Document Type: Article

References (37)

1. Riess ML, Stowe DF, Warltier DC. Cardiac pharmacological preconditioning with volatile anesthetics: From bench to bedside? Am. J. Physiol. Heart Circ. Physiol. 2004 286 : H1603 7.
2. Tanaka K, Ludwig LM, Kersten JR, Pagel PS, Warltier DC. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004 100 : 707 21.
3. Chiari PC, Pagel PS, Tanaka K et al. Intravenous emulsified halogenated anesthetics produce acute and delayed preconditioning against myocardial infarction in rabbits. Anesthesiology 2004 101 : 1160 6.
4. Rao Y, Wang YL, Zhang WS, Liu J. Emulsified isoflurane produces cardiac protection after ischemia-reperfusion injury in rabbits. Anesth. Analg. 2008 106 : 1353 9.
5. Lucchinetti E, Schaub MC, Zaugg M. Emulsified intravenous versus evaporated inhaled isoflurane for heart protection: Old wine in a new bottle or true innovation? Anesth. Analg 2008 106 : 1346 9.
6. De Hert SG. Cardioprotection with volatile anesthetics: Clinical relevance. Curr. Opin. Anaesthesiol. 2004 17 : 57 62.
7. Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischaemic preconditioning. Cardiovasc. Res. 2002 55 : 438 55.
8. Zaugg M, Jamali NZ, Lucchinetti E, Shafiq SA, Siddiqui MA. Norepinephrine-induced apoptosis is inhibited in adult rat ventricular myocytes exposed to volatile anesthetics. Anesthesiology 2000 93 : 209 18.
9. James TN. Apoptosis in cardiac disease. Am. J. Med. 1999 107 : 606 20.
10. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 1997 275 : 1132 6.
11. 2+ concentration within the endoplasmic reticulum. Proc. Natl Acad. Sci. USA 2000 97 : 5723 8.
12. Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 1998 60 : 619 42.
13. Green D, Kroemer G. The central executioners of apoptosis: Caspases or mitochondria? Trends Cell. Biol. 1998 8 : 267 71.
14. Zhou JX, Luo NF, Liang XM, Liu J. The efficacy and safety of intravenous emulsified isoflurane in rats. Anesth. Analg. 2006 102 : 129 34.
15. Yang XL, Ma HX, Yang ZB et al. Comparison of minimum alveloar concentration between intravenous isoflurane lipid emulsion and inhaled isoflurane in dogs. Anesthesiology 2006 104 : 482 7.
16. Fan LL, Ma J, Wang YF, Ruan YM, Zeng XK. Effects of oxyphenamone on myocardial ischemia in cats and rats. Acta Pharm. Sin. 2005 40 : 122 6.
17. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation 1996 94 : 1506 12.
18. Patel HH, Tsutsumi YM, Head BP et al. Mechanisms of cardiac protection from ischemia/reperfusion injury: A role for caveolae and caveolin-1. FASEB J. 2007 21 : 1565 74.
19. Downey JM. Ischemic preconditioning: Nature's own cardioprotective intervention. Trends Cardiovasc. Med. 1992 2 : 170 6.
20. Preckel B, Schlack W, Comfère T, Obal D, Barthel H, Thämer V. Effects of enflurane, isoflurane, sevoflurane and desflurane on reperfusion injury after regional myocardial ischaemia in the rabbit heart in vivo. Br. J. Anaesth. 1998 81 : 905 12.
21. ATP channels. Am. J. Physiol. 1997 272 : H334 42.
22. ATP channels: Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997 87 : 361 70.
23. ATP channels and opioid receptors. Anesthesiology 2003 98 : 705 11.
24. Tanaka K, Weihrauch D, Kehl F et al. Mechanism of preconditioning by isoflurane in rabbits: A direct role for reactive oxygen species. Anesthesiology 2002 97 : 1485 90.
25. Kurien VA, Oliver MF. Free fatty acids during acute myocardial infarction. Prog. Cardiovasc. Dis. 1971 13 : 361 73.
26. Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR. Is isoflurane-induced preconditioning dose related? Anesthesiology 2002 96 : 675 80.
27. Metzler B, Mair J, Lercher A et al. Mouse model of myocardial remodelling after ischemia: Role of intercellular adhesion molecule-1. Cardiovasc. Res. 2001 49 : 399 407.
28. Mohanty I, Arya DS, Gupta SK. Effect of Curcuma longa and Ocimum sanctum on myocardial apoptosis in experimentally induced myocardial ischemic-reperfusion injury. BMC Complement. Altern. Med. 2006 6 : 3.
29. Belhomme D, Peynet J, Louzy M, Launay JM, Kitakaze M, Menasché P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999 100 : 340 4.
30. Jamnicki-Abegg M, Weihrauch D, Pagel PS et al. Isoflurane inhibits cardiac myocyte apoptosis during oxidative and inflammatory stress by activating Akt and enhancing Bcl-2 expression. Anesthesiology 2005 103 : 1006 14.
31. Raphael J, Abedat S, Rivo J et al. Volatile anesthetic preconditioning attenuates myocardial apoptosis in rabbits after regional ischemia and reperfusion via Akt signaling and modulation of Bcl-2 family proteins. J. Pharmacol. Exp. Ther. 2006 318 : 186 94.
32. Grünenfelder J, Miniati DN, Murata S et al. Upregulation of Bcl-2 through caspase-3 inhibition ameliorates ischemia/reperfusion injury in rat cardiac allografts. Circulation 2001 104 : 202 6.
33. Ma XL, Kumar S, Gao F et al. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 1999 99 : 1685 91.
34. Cheng EH, Kirsch DG, Clem RJ et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 1997 278 : 1966 8.
35. Kim YM, Kim TH, Seol DW et al. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release. J. Biol. Chem. 1998 273 : 3137 44.
36. Yang XP, Liu YH, Rhaleb NE, Kurihara N, Kim HE, Carretero OA. Echocardiographic assessment of cardiac function in conscious and anesthetized mice. Am. J. Physiol. 1999 277 : H1967 74.
37. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischaemic rabbit myocardium from infarction. Anesthesiology 1997 86 : 699 709.